Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23136909 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in Africa
Condition: Malaria
Interventions: Biological: Malaria Vaccine 257049;   Biological: Meningococcal C Conjugate Vaccine;   Biological: Cell-culture rabies vaccine;   Biological: TritanrixHepB/Hib;   Biological: Polio Sabin Oral Polio Vaccine (GSK)

Indicates status has not been verified in more than two years